Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark C. Schneyer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James M. Daly - $671K of ACAD open-market activity in the last 12 months
- James Kihara - $603K of ACAD open-market activity in the last 12 months
- Elizabeth H.Z. Thompson - $506K of ACAD open-market activity in the last 12 months
- Adams Catherine Owen - $250K of ACAD open-market activity in the last 12 months
- Jennifer J. Rhodes - $245K of ACAD open-market activity in the last 12 months
- Elizabeth A. Garofalo - $42K of ACAD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mark C. Schneyer?
Mark C. Schneyer is a corporate insider, tracked as EVP, CHIEF FINANCIAL OFFICER of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark C. Schneyer submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mark C. Schneyer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($2.08M) across all tracked filings.
Where can I see all of Mark C. Schneyer's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mark C. Schneyer and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
